About SkinJect
SkinJect is a company based in Pittsburgh (United States) founded in 2015. It operates as a HealthTech. SkinJect has raised $3.4 million across 4 funding rounds from investors including Velocity Fund Partners. SkinJect offers products and services including SkinJect Patch. SkinJect operates in a competitive market with competitors including Enable Injections, Aura Biosciences, Philogen, Micron Biomedical and OnQuality, among others.
- Headquarter Pittsburgh, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.4 M (USD)
in 4 rounds
-
Latest Funding Round
$895.09 K (USD), Series A
Jul 15, 2021
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SkinJect
SkinJect offers a comprehensive portfolio of products and services, including SkinJect Patch.
A microneedle patch developed for skin cancer treatment.
People of SkinJect
Unlock access to complete
Unlock access to complete
Funding Insights of SkinJect
SkinJect has successfully raised a total of $3.4M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $895.09 thousand completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in SkinJect
SkinJect has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Velocity Fund Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward USA-based companies.
|
Locked | Locked | Locked |
Investor details for SkinJect
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SkinJect
Investment portfolio details for SkinJect
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SkinJect
Detailed financials for SkinJect
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Skinject Comparisons
Peer comparison for SkinJect
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SkinJect
SkinJect operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enable Injections, Aura Biosciences, Philogen, Micron Biomedical and OnQuality, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of a wearable drug delivery solution
|
|
| Locked | Locked | Locked |
Therapies are developed to target and destroy cancer cells selectively.
|
|
| Locked | Locked | Locked |
Antibody-based drugs are developed for angiogenesis-related cancers and disorders.
|
|
| Locked | Locked | Locked |
Microneedle patches are developed for vaccine and drug delivery.
|
|
| Locked | Locked | Locked |
Therapeutics for skin cancers and related reactions are developed.
|
|
| Locked | Locked | Locked |
Develops innovative transdermal drug delivery technologies for various therapeutic applications.
|
Detailed competitors of SkinJect
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Skinject
Complete news archive for SkinJect
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SkinJect
SkinJect was founded in 2015.
SkinJect is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
James M Nolan is the current CEO of SkinJect.
SkinJect is a funded company, having raised a total of $3.4M across 4 funding rounds to date.
SkinJect is engaged in the development of innovative solutions for treating basal cell and squamous cell skin cancer. A dissolvable microneedle patch is being created as a less invasive and less painful treatment option. The company operates in the dermatology sector, addressing an unmet clinical need with a focus on reducing recurrence rates. Efforts are directed toward advancing technologies and securing regulatory clearances for commercialization in a competitive market.
SkinJect's top competitors include Philogen, Enable Injections and Aura Biosciences.
SkinJect offers SkinJect Patch.
SkinJect has 1 investor. Key investors include Velocity Fund Partners.